Company: BNBX
Filing Date: 2025-01-17
Form Type: 424B3
Source: 0001104659-25-004510
Chunk: 23

Company: BNB PLUS CORP.
Filing Date: 2025-01-17
Form: 424B3
Chunk 23
---
 exercise price in the event of a reverse split of our Common Stock, to a price equal to the lesser of (i) the
then exercise price and (ii) lowest volume weighted average price (VWAP) during the period commencing five trading days immediately
preceding and the five trading days commencing on the date we effect a reverse stock split in the future with a proportionate adjustment
to the number of shares underlying the Series D Warrants, subject to a floor of $0.0634.

If any of the above provisions in the Series Warrants are utilized,
our stockholders may suffer substantial dilution.

The exercisability of the Private Placement Warrants is contingent upon us obtaining Warrant Stockholder Approval. If we do not obtain such Warrant Stockholder Approval, the Private Placement Warrants may never become exercisable.

The Private Placement Warrants are not immediately
exercisable, as their exercisability is contingent upon us obtaining Warrant Stockholder Approval. The Private Placement Warrants
will become exercisable upon the Stockholder Approval Date and will expire on the five-year anniversary of such date with respect to
the Series C Warrants, and on the eighteen-month anniversary of such date with respect to the Series D Warrants. The Placement
Agent Warrants will become exercisable upon the Stockholder Approval Date and will expire on October 30, 2029. While we intend to
promptly seek Warrant Stockholder Approval for these mechanisms, there is no guarantee that it will ever be obtained. In the event that
we cannot obtain Warrant Stockholder Approval, the Private Placement Warrants may never become exercisable. If we are
unable to obtain Warrant Stockholder Approval, the Private Placement Warrants will have no value.

<div align='center'>9</div>

We have agreed to hold the Special Meeting
on January 23, 2025 in order to obtain Warrant Stockholder Approval. There is no guarantee we will be able to hold the Special Meeting
on this date, or at all. If we do not obtain Warrant Stockholder Approval at the Special Meeting, we are obligated to call a meeting
every ninety days thereafter to seek Warrant Stockholder Approval until the earlier of the date on which Stockholder Approval is obtained
or the Series Warrants are no longer outstanding.

There are a large number of shares of Common Stock underlying our outstanding options and warrants and the sale of these shares may depress the market price of our Common Stock and cause immediate and substantial dil